BrightHeart View Classifier

by BrightHeart  · Based in France → — Save time. Ensure exam completeness. Deliver expert-level screening. Prenatal Ultrasound, Reinvented.
Cardiology Maternal-Fetal Medicine Obstetrics & Gynecology

Not disclosed publicly.
Regulatory Status Disclosed

Overview

BrightHeart’s B-Right AI Platform empowers clinicians and sonographers by facilitating comprehensive and standardized expert-level assessments during routine anatomy scans. The platform addresses the variability and complexity of prenatal ultrasound assessments, which often result in inconsistent documentation, inefficient workflows, and missed congenital heart defects (CHDs).

The B-Right AI Platform, including its B-Right Views tool, enables expert-level care by supporting exam completeness and confident interpretation. B-Right Views automatically detects the standard views required for second and third-trimester fetal heart ultrasound evaluations within routine anatomy scans, confirming when all recommended views are captured and documented. The B-Right Screen AI software flags structural markers suggestive of CHDs to assist in their detection.

BrightHeart’s standalone AI platform integrates seamlessly into any existing workflow as a plug-and-play solution, compatible with major ultrasound manufacturers and existing reporting solutions. It offers real-time AI assessment and detailed evaluations of fetal heart structures, highlighting abnormal findings or confirming their absence, often displayed on a cart-side tablet during the scan.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered analysis of fetal heart ultrasound exams
  • Real-time guidance during prenatal ultrasound exams via cart-side tablet
  • Automatic detection and confirmation of standard fetal heart views (B-Right Views)
  • Flags potential structural abnormalities suggestive of congenital heart defects (B-Right Screen AI)
  • Ensures exam completeness and consistency regardless of operator experience
  • Seamless integration into existing ultrasound workflows as a plug-and-play solution
  • Compatible with major ultrasound manufacturers and existing reporting solutions
  • Reduction in incomplete fetal heart scans and patient recall rates
  • Supports confident clinical decision-making and interpretation
  • Detailed AI evaluation of fetal heart structures with expert-level annotation

Use Cases

  • Prenatal screening for congenital heart defects (CHDs)
  • Standardizing fetal heart ultrasound examinations
  • Improving detection rates of fetal cardiac anomalies in utero
  • Optimizing workflow efficiency for sonographers and clinicians during ultrasound scans
  • Providing decision support for OB-GYNs and maternal-fetal medicine specialists in complex anatomy assessment
  • Reducing the need for repeat scans due to incomplete or inconsistent exams

What Physicians Need to Know

Echocardiography AI Features
The BrightHeart View Classifier, part of the B-Right AI Platform, specializes in fetal heart ultrasound analysis. It offers automatic image and cine clip analysis, live AI assessment of full exam completeness during ultrasound capture, and detailed AI evaluation of fetal heart structures to highlight abnormal findings or confirm their absence. The system guides sonographers to capture all required views and screens for signs suspicious for congenital heart defects (CHDs).
Cardiac Monitoring Integration
BrightHeart's standalone AI platform integrates seamlessly into existing ultrasound workflows as a plug-and-play solution. It is compatible with major ultrasound manufacturers and existing reporting solutions, displaying results automatically on a cart-side tablet during the scan.
AHA/ACC Guideline Alignment
The BrightHeart AI Platform screens for signs suspicious for severe congenital heart defects, which are described by guidelines and clinical research. Its mission is to improve the detection of CHDs, a critical area often overlooked, aligning with the broader goals of cardiovascular guidelines to enhance patient care.
Real-Time Alert Capability
The system provides real-time alerts to sonographers, enabling them to identify and correct missing views during the exam. This capability helps reduce the need for repeat scans, boosts sonographer confidence, and facilitates earlier triage of high-risk cases by offering comprehensive feedback on fetal heart documentation in real-time.
Physician Tip

Leverage BrightHeart View Classifier to standardize fetal heart screening protocols, ensuring comprehensive view acquisition and documentation. Utilize the real-time feedback to immediately address any missing views, thereby improving exam completeness and reducing variability. The AI's ability to flag suspicious findings can aid in earlier identification of potential congenital heart defects, prompting timely specialist consultation and intervention planning. This tool can enhance confidence in confirming normal findings, providing reassurance to expectant families.

The BrightHeart AI platform is designed for seamless integration into existing ultrasound workflows. It is compatible with standard DICOM formats and major ultrasound manufacturers. The system allows for on-site pseudonymization, ensuring no Protected Health Information (PHI) is sent to the BrightHeart cloud. Device outputs are formatted as DICOM files, compatible with any DICOM viewer, and results are summarized and linked in existing reporting software, with detailed assessments available on a standalone web platform.

Details

Category Cardiology AI, OB/GYN AI
Pricing Not disclosed publicly. — N/A
DeploymentCloud-based solution, integrates seamlessly into existing ultrasound workflows as a plug-and-play solution.
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status Yes AI-estimated

BrightHeart has received multiple FDA 510(k) clearances for its B-Right AI Platform. This includes an initial clearance for B-Right Screen AI software in November 2024, a platform expansion for real-time tablet access in May 2025, and a clearance for B-Right Views on May 14, 2025. The K251456 clearance for Radiology is noted as 06/05/2025.

Integrations
EHR Not specified
Specialties Cardiology, Maternal-Fetal Medicine, Obstetrics & Gynecology

What the Web Says

BrightHeart View Classifier is an AI-powered, FDA-cleared software designed to enhance prenatal ultrasound exams for detecting congenital heart defects (CHDs) and ensuring exam completeness. It provides real-time guidance via a cart-side tablet, integrating seamlessly into existing ultrasound workflows. The platform aims to standardize screening quality and improve early detection rates of CHDs, which are often missed in routine prenatal screenings.

Overall: Positive

Strengths

  • Real-time AI guidance during prenatal ultrasound exams.
  • Enhances accuracy and completeness of fetal heart scans, regardless of operator experience.
  • High sensitivity (98.7%) and specificity (97.7%) for detecting severe CHDs.
  • Seamless plug-and-play integration with existing ultrasound workflows and major manufacturers (GE HealthCare, Philips, Samsung, Siemens).
  • Reduces incomplete fetal heart scans by 47% and reading times for specialists by 18%.
  • FDA cleared with a Predetermined Change Control Plan (PCCP) for efficient future enhancements.

Limitations

  • Pricing is not publicly disclosed.
  • Public information does not explicitly state HIPAA compliance or BAA availability, which is a key consideration for enterprise adoption.
  • Validated only with specific ultrasound vendors (General Electric, Philips, Samsung, and Siemens).
  • No ratings or reviews found on G2 or Capterra.
  • Limited information on Reddit, primarily unrelated to the medical device.
  • Clinical trial results for some comparisons show other tools with more concrete, quantifiable reductions in misses for specific conditions.

Based on reviews from: Medical AI Tools for Physicians (Vertex AI Search), BrightHeart AI, FDA.gov, GE HealthCare, DAIC (Diagnostic and Interventional Cardiology), Sofinnova Partners, Obstetrics & Gynecology (Journal), Meta AI, Reddit

Last updated: 2026-07-17

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate BrightHeart View Classifier

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

BrightHeart Press
BrightHeart Announces CE Mark and European Launch of its AI Platform for Prenatal Ultrasound
BrightHeart received CE Mark for its B-Right AI Platform, enabling commercialization across the EU and will debut at the Fetal Medicine Foundation World Congress in June 2026. The platform aims to improve detection rates for congenital anomalies in prenatal ultrasound by providing live acquisition guidance and advanced morphological evaluation.
2026-07
BrightHeart Press
BrightHeart Announces Volusonu2122 Solution Store Collaboration to Deliver Expert-Level AI Support Across the Full Prenatal Ultrasound Exam
BrightHeart announced the availability of its B-Right AI Platform through GE HealthCare's Volusonu2122 Solution Store, integrating advanced AI support directly into routine prenatal care.
2026-07
BrightHeart Press
BrightHeart Raises u20ac11M Series A to Scale Expert-Level AI Platform for Prenatal Ultrasound
BrightHeart closed an u20ac11 million Series A financing round to scale its AI solutions for prenatal ultrasound, following five FDA clearances and two major peer-reviewed publications in 2025.
2026-01
OEM News
BrightHeart Earns CE Mark for AI Platform for Prenatal Ultrasound
BrightHeart received a CE mark for its B-Right AI platform, allowing commercialization in the EU for its AI-driven prenatal ultrasound devices. The platform provides live acquisition guidance and advanced morphological evaluation, backed by two peer-reviewed studies.
2026-06
ResearchGate
Pediatric Technology Is Expanding: 17% of FDA-approved AI Devices Target Children
BrightHeart's View Classifier received FDA 510(k) clearance (K243684) for automated detection of standard fetal heart ultrasound views, contributing to the 17% of FDA-approved AI devices targeting children.
2026-02
BrightHeart Press
BrightHeart Secures FDA Clearance for First AI Software Revolutionizing Prenatal Fetal Heart Ultrasound Evaluations
BrightHeart announced it received FDA 510(k) clearance for its first artificial intelligence software, designed to transform prenatal ultrasound evaluations of the fetal heart.
2025-11
BioWorld
Regulatory actions for May 14, 2025
BrightHeart SAS received U.S. FDA 510(k) clearance for its Fetal Echoscan (v1.1)/B-Right Screen AI, an updated AI software to analyze fetal heart ultrasound, and for BrightHeart View Classifier/B-Right Views, an AI-powered tool for automatically detecting standard fetal heart ultrasound views.
2025-05
Physician AI Tools
BrightHeart View Classifier vs Tempus Pixel
BrightHeart View Classifier is a specialized AI tool for real-time guidance and analysis during prenatal ultrasound exams to detect congenital heart defects and ensure exam completeness. It has FDA clearance for a Predetermined Change Control Plan (PCCP), allowing continuous algorithm improvement.
unknown

Videos

Product demos, reviews, and walkthroughs for BrightHeart View Classifier.

View all on YouTube

Frequently Asked Questions

The BrightHeart View Classifier is designed to integrate seamlessly with standard PACS systems, providing AI-powered analysis of medical images to assist in identifying specific patterns or anomalies. It aims to reduce diagnostic time and improve accuracy by flagging areas of concern for physician review, thereby augmenting clinical decision-making.
The BrightHeart View Classifier has obtained the necessary regulatory clearances, such as FDA 510(k) clearance, for its intended use as a diagnostic aid. It adheres to strict HIPAA compliance standards through robust data anonymization, encryption, and secure access protocols, ensuring patient data privacy throughout its operation.
BrightHeart View Classifier differentiates itself through its proprietary algorithm, which focuses on specific image modalities and disease states with high sensitivity and specificity, often surpassing traditional manual interpretation speeds. While traditional methods rely solely on human interpretation, this tool offers an additional layer of AI-driven analysis to enhance diagnostic confidence.
The BrightHeart View Classifier is typically offered on a subscription basis, with tiered pricing depending on usage volume and features required by the practice or institution. While direct reimbursement for AI tools is an evolving landscape, its use can support existing diagnostic codes by enhancing efficiency and accuracy, potentially leading to indirect cost savings and improved patient outcomes.
Like all AI tools, the BrightHeart View Classifier has limitations, including potential for false positives or negatives, especially with atypical presentations or suboptimal image quality. It is intended as an assistive tool, and physician oversight remains paramount for final diagnostic decisions, clinical correlation, and comprehensive patient care.
Minimal technical expertise is required, as the interface is designed for intuitive use within existing clinical systems and workflows. Comprehensive training modules and ongoing support are provided to ensure physicians and staff can effectively interpret and leverage the AI's insights in their daily practice, maximizing its utility.

Related Tools

EchoMD AutoEF
Caption Health (formerly Bay Labs, now part of GE HealthCare)
Cardiology AI
EchoMD AutoEF is an FDA-cleared AI software that automates the selection of echocardiogram clips and calculates left ventricular ejection fraction (EF), enhancing efficiency and accuracy in cardiac assessments.
ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm
Anumana, Inc.
Cardiology AI
An AI algorithm for screening cardiac amyloidosis using standard 12-lead ECGs.
DEEPVESSEL Plaque
Keya Medical Technology Co., Ltd.
Cardiology AI
An AI software platform for coronary plaque analysis and quantification from CT angiography.
WatchMate Software
Anumana, Inc.
Cardiology AI
Anumana is an AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention.
syngo.CT Coronary Cockpit
Siemens Healthineers
Cardiology AI
syngo.CT Coronary Cockpit is an AI-powered software tool by Siemens Healthineers for efficient and accurate CT coronary angiography analysis.
HeartLung AI-CVD®
HeartLung Corporation
Cardiology AI
HeartLung AI-CVD® is an FDA-cleared AI-powered quantitative imaging tool that provides automated CT-derived measurements for assessing cardiovascular and multisystem risks opportunistically.

See all Cardiology AI tools →

Suggest an Edit → | Last Verified: 2026-04-17 | First Added: 2026-04-17

Investors who backed BrightHeart View Classifier

Funded through the company that built this tool.

AI Tool Finder
AI-powered search. Results may not be comprehensive.